Best Angiotensin Receptor Blocker (ARB) for Blood Pressure Control
There is no single "best" ARB for blood pressure control, as all ARBs have similar efficacy in lowering blood pressure, with the choice depending on specific patient factors and comorbidities. 1
Efficacy of ARBs
ARBs are one of the four major classes of antihypertensive medications proven to reduce cardiovascular events, alongside:
- ACE inhibitors
- Dihydropyridine calcium channel blockers (CCBs)
- Thiazide/thiazide-like diuretics 1
All available ARBs effectively lower blood pressure with minimal differences between agents in their antihypertensive efficacy. The 2014 hypertension guidelines review noted an "absence of conclusive clinical evidence to demonstrate that a specific drug class is superior" 1.
Patient-Specific Selection Factors
The choice of ARB should be guided by:
Comorbid conditions:
Dosing considerations:
- Most ARBs can be administered once daily
- Some patients may benefit from twice-daily dosing for better 24-hour coverage 3
Special populations:
Monitoring and Safety
When using any ARB:
- Monitor serum creatinine and potassium levels at initiation and at least annually 1
- Never combine ARBs with ACE inhibitors due to increased risk of hyperkalemia, hypotension, and renal dysfunction 1, 2
- Watch for hypotension, particularly in volume-depleted patients 4, 5
Treatment Algorithm
Initial therapy:
If target not achieved:
Resistant hypertension:
- For patients not meeting targets on three medications (including a diuretic), consider adding a mineralocorticoid receptor antagonist 1
Specific ARB Considerations
While all ARBs are generally effective and well-tolerated, there are some differences worth noting:
Losartan: May have uricosuric effects (lowers uric acid levels) 6, but some evidence suggests 50mg may be too low a dose and 100mg daily may be more effective 7
Telmisartan: Has additional indication for cardiovascular risk reduction in patients unable to take ACE inhibitors 4
Azilsartan: Some studies suggest superior blood pressure reduction compared to valsartan and olmesartan at maximum doses 8
Common Pitfalls to Avoid
Underdosing: Some ARBs may require higher doses for optimal effect (e.g., losartan may be more effective at 100mg than 50mg) 7
Inappropriate combinations: Never combine ARBs with ACE inhibitors or direct renin inhibitors 1
Inadequate monitoring: Failure to check renal function and potassium levels after initiation 1
Continuing during pregnancy: ARBs must be discontinued when pregnancy is detected 4, 5
Overlooking timing: Consider twice-daily dosing in non-dippers (patients without normal nocturnal BP decrease) 3